AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
NYSE:AMN - New York Stock Exchange, Inc. - US0017441017 - Common Stock - Currency: USD
Overall AMN gets a fundamental rating of 5 out of 10. We evaluated AMN against 109 industry peers in the Health Care Providers & Services industry. AMN scores excellent on profitability, but there are some minor concerns on its financial health. AMN has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
AMN had a positive operating cash flow in the past year.
AMN had positive earnings in each of the past 5 years.
Each year in the past 5 years AMN had a positive operating cash flow.
1.2 Ratios
The Return On Assets of AMN (1.99%) is better than 63.89% of its industry peers.
AMN has a Return On Equity of 5.96%. This is in the better half of the industry: AMN outperforms 67.59% of its industry peers.
With a Return On Invested Capital value of 4.59%, AMN perfoms like the industry average, outperforming 57.41% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AMN is significantly above the industry average of 8.15%.
The last Return On Invested Capital (4.59%) for AMN is well below the 3 year average (17.26%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.99% | ||
| ROE | 5.96% | ||
| ROIC | 4.59% |
ROA(3y)11.01%
ROA(5y)8.39%
ROE(3y)32.02%
ROE(5y)24.03%
ROIC(3y)17.26%
ROIC(5y)13.59%
1.3 Margins
AMN has a Profit Margin of 1.73%. This is in the better half of the industry: AMN outperforms 64.81% of its industry peers.
In the last couple of years the Profit Margin of AMN has declined.
With a decent Operating Margin value of 4.37%, AMN is doing good in the industry, outperforming 62.04% of the companies in the same industry.
AMN's Operating Margin has been stable in the last couple of years.
AMN's Gross Margin of 31.34% is in line compared to the rest of the industry. AMN outperforms 56.48% of its industry peers.
AMN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.37% | ||
| PM (TTM) | 1.73% | ||
| GM | 31.34% |
OM growth 3Y1.49%
OM growth 5Y-1.21%
PM growth 3Y23.47%
PM growth 5Y-3.47%
GM growth 3Y-0.1%
GM growth 5Y0.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), AMN is creating value.
AMN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for AMN has been reduced compared to 5 years ago.
Compared to 1 year ago, AMN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.50 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score (2.50) which is comparable to the rest of the industry.
The Debt to FCF ratio of AMN is 10.26, which is on the high side as it means it would take AMN, 10.26 years of fcf income to pay off all of its debts.
AMN has a Debt to FCF ratio (10.26) which is in line with its industry peers.
AMN has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.27, AMN is doing worse than 68.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 10.26 | ||
| Altman-Z | 2.5 |
ROIC/WACC0.67
WACC6.83%
2.3 Liquidity
AMN has a Current Ratio of 1.18. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AMN (1.18) is worse than 66.67% of its industry peers.
AMN has a Quick Ratio of 1.18. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
AMN has a Quick ratio (1.18) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.37%.
AMN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.92% yearly.
AMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.12%.
Measured over the past years, AMN shows a quite strong growth in Revenue. The Revenue has been growing by 12.15% on average per year.
EPS 1Y (TTM)-58.37%
EPS 3Y33.37%
EPS 5Y19.92%
EPS Q2Q%-69.04%
Revenue 1Y (TTM)-25.12%
Revenue growth 3Y16.55%
Revenue growth 5Y12.15%
Sales Q2Q%-19.44%
3.2 Future
Based on estimates for the next years, AMN will show a decrease in Earnings Per Share. The EPS will decrease by -0.91% on average per year.
The Revenue is expected to decrease by -1.97% on average over the next years.
EPS Next Y-62.44%
EPS Next 2Y-54.99%
EPS Next 3Y-32.79%
EPS Next 5Y-0.91%
Revenue Next Year-21.97%
Revenue Next 2Y-15.68%
Revenue Next 3Y-9.12%
Revenue Next 5Y-1.97%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.09 indicates a rather cheap valuation of AMN.
Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 98.15% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.46, AMN is valued rather cheaply.
A Price/Forward Earnings ratio of 16.65 indicates a correct valuation of AMN.
Based on the Price/Forward Earnings ratio, AMN is valued a bit cheaper than 72.22% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.56, AMN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.09 | ||
| Fwd PE | 16.65 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 91.67% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 92.59% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.51 | ||
| EV/EBITDA | 7.01 |
4.3 Compensation for Growth
AMN has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as AMN's earnings are expected to decrease with -32.79% in the coming years.
PEG (NY)N/A
PEG (5Y)0.36
EPS Next 2Y-54.99%
EPS Next 3Y-32.79%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMN HEALTHCARE SERVICES INC
NYSE:AMN (1/31/2025, 8:10:44 PM)
After market: 27.52 0 (0%)27.52
-0.58 (-2.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners117.49%
Inst Owner Change0.52%
Ins Owners0.36%
Ins Owner Change4.9%
Market Cap1.05B
Analysts69.23
Price Target40.8 (48.26%)
Short Float %10.69%
Short Ratio3.79
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.69%
Min EPS beat(2)5.34%
Max EPS beat(2)28.04%
EPS beat(4)4
Avg EPS beat(4)9.54%
Min EPS beat(4)0.39%
Max EPS beat(4)28.04%
EPS beat(8)8
Avg EPS beat(8)10.81%
EPS beat(12)12
Avg EPS beat(12)10.19%
EPS beat(16)16
Avg EPS beat(16)12.66%
Revenue beat(2)1
Avg Revenue beat(2)0.21%
Min Revenue beat(2)-0.96%
Max Revenue beat(2)1.38%
Revenue beat(4)2
Avg Revenue beat(4)0.21%
Min Revenue beat(4)-0.96%
Max Revenue beat(4)1.38%
Revenue beat(8)4
Avg Revenue beat(8)0.5%
Revenue beat(12)8
Avg Revenue beat(12)1.17%
Revenue beat(16)11
Avg Revenue beat(16)2.26%
PT rev (1m)-3.11%
PT rev (3m)-26.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.09 | ||
| Fwd PE | 16.65 | ||
| P/S | 0.34 | ||
| P/FCF | 9.51 | ||
| P/OCF | 5.07 | ||
| P/B | 1.18 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.01 |
EPS(TTM)3.88
EY14.1%
EPS(NY)1.65
Fwd EY6.01%
FCF(TTM)2.89
FCFY10.52%
OCF(TTM)5.42
OCFY19.71%
SpS80.57
BVpS23.4
TBVpS-16.51
PEG (NY)N/A
PEG (5Y)0.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.99% | ||
| ROE | 5.96% | ||
| ROCE | 6.24% | ||
| ROIC | 4.59% | ||
| ROICexc | 4.66% | ||
| ROICexgc | 16.47% | ||
| OM | 4.37% | ||
| PM (TTM) | 1.73% | ||
| GM | 31.34% | ||
| FCFM | 3.59% |
ROA(3y)11.01%
ROA(5y)8.39%
ROE(3y)32.02%
ROE(5y)24.03%
ROIC(3y)17.26%
ROIC(5y)13.59%
ROICexc(3y)18.1%
ROICexc(5y)14.21%
ROICexgc(3y)63.19%
ROICexgc(5y)49.77%
ROCE(3y)23.43%
ROCE(5y)18.46%
ROICexcg growth 3Y6.33%
ROICexcg growth 5Y0.89%
ROICexc growth 3Y12.07%
ROICexc growth 5Y-2.64%
OM growth 3Y1.49%
OM growth 5Y-1.21%
PM growth 3Y23.47%
PM growth 5Y-3.47%
GM growth 3Y-0.1%
GM growth 5Y0.23%
F-Score5
Asset Turnover1.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 10.26 | ||
| Debt/EBITDA | 3.65 | ||
| Cap/Depr | 54.87% | ||
| Cap/Sales | 3.14% | ||
| Interest Coverage | 2.19 | ||
| Cash Conversion | 66.71% | ||
| Profit Quality | 207.78% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 2.5 |
F-Score5
WACC6.83%
ROIC/WACC0.67
Cap/Depr(3y)58.76%
Cap/Depr(5y)56.04%
Cap/Sales(3y)1.89%
Cap/Sales(5y)1.79%
Profit Quality(3y)110.83%
Profit Quality(5y)161.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-58.37%
EPS 3Y33.37%
EPS 5Y19.92%
EPS Q2Q%-69.04%
EPS Next Y-62.44%
EPS Next 2Y-54.99%
EPS Next 3Y-32.79%
EPS Next 5Y-0.91%
Revenue 1Y (TTM)-25.12%
Revenue growth 3Y16.55%
Revenue growth 5Y12.15%
Sales Q2Q%-19.44%
Revenue Next Year-21.97%
Revenue Next 2Y-15.68%
Revenue Next 3Y-9.12%
Revenue Next 5Y-1.97%
EBIT growth 1Y-68.35%
EBIT growth 3Y18.28%
EBIT growth 5Y10.78%
EBIT Next Year-20.38%
EBIT Next 3Y-12.37%
EBIT Next 5YN/A
FCF growth 1Y-79.79%
FCF growth 3Y7.01%
FCF growth 5Y6.96%
OCF growth 1Y-66.5%
OCF growth 3Y13.17%
OCF growth 5Y10.39%